Axsome Therapeutics has a twelve month low of $64.11 and a twelve month high of $139.13. The company has a market capitalization of $5.96 billion, a price-to-earnings ratio of -20.40 and a beta of ...

Axsome Therapeutics règle le litige relatif au brevet Sunosi avec Hikma 05/03 MT Axsome Therapeutics reçoit une indication de la FDA à l'appui d'une demande d'autorisation de mise sur le ...

NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. The FDA has cleared ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: March 10 at 6:31:15 p.m. EDT Loading Chart for AXSM ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.